Home » West Pharmaceutical Acquires Monarch Analytical
News
Posted On: 02/18/2005
West Pharmaceutical Acquires Monarch Analytical
West Pharmaceutical Services, Inc., Lionville, Pa., recently purchased Monarch Analytical Laboratories, Inc. of Maumee, Ohio. Monarch had 2004 sales of approximately $3 million and West is acquiring all of the outstanding stock of Monarch Analytical Laboratories in exchange for cash, assumed liabilities and West shares totaling $5.6 million.
Monarch provides some of the largest U.S. pharmaceutical and medical device companies with a variety of analytical testing services. West also provides analytical laboratory services, in addition to manufacturing essential components and systems for injectable drug delivery. The combined laboratories will operate under the name West Monarch Analytical Laboratories. West plans to continue operating both the Pennsylvania and Ohio facilities and to retain the majority of Monarch’s 20 employees.
West Monarch Analytical Laboratories will offer a comprehensive menu of sophisticated analytical testing services for glass, plastics and elastomer packaging components to help global pharmaceutical manufacturers meet worldwide container/closure and packaging regulatory guidelines. Monarch’s extensive capabilities and experience in glass and plastics testing will complement West’s extensive portfolio of services, most significantly, extractable and leachable testing for elastomer components, which West manufactures and which represent its largest product group.
"Monarch Analytical Laboratories represents an excellent strategic fit that enables West to provide our customers with a broader range of analytical testing services," said Herbert L. Hugill, President of the Americas Region, West Pharmaceutical Services. "Monarch’s expertise and experience in testing nasal and inhalation devices brings added strengths to West’s current portfolio of services. Together, we can better assist our pharmaceutical clients to develop data that is critical to their product-related regulatory submissions. They, in turn, can focus their resources on discovering and developing new drugs, biologics and medical devices."
For more information, visit West at www.westpharma.com.